These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31050072)

  • 1. Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1.
    Yong L; Ma Y; Liang C; He G; Zhao Z; Yang C; Hai B; Pan X; Liu Z; Liu X
    Phytother Res; 2019 Jul; 33(7):1837-1850. PubMed ID: 31050072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oleandrin synergizes with cisplatin in human osteosarcoma cells by enhancing cell apoptosis through activation of the p38 MAPK signaling pathway.
    Yong L; Ma Y; Zhu B; Liu X; Wang P; Liang C; He G; Zhao Z; Liu Z; Liu X
    Cancer Chemother Pharmacol; 2018 Dec; 82(6):1009-1020. PubMed ID: 30267330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells.
    Beretta GL; Gatti L; Tinelli S; Corna E; Colangelo D; Zunino F; Perego P
    Biochem Pharmacol; 2004 Jul; 68(2):283-91. PubMed ID: 15194000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
    Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
    Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of cisplatin to intraperitoneal ovarian carcinomas mediated by the effects of bortezomib on the human copper transporter 1.
    Jandial DD; Farshchi-Heydari S; Larson CA; Elliott GI; Wrasidlo WJ; Howell SB
    Clin Cancer Res; 2009 Jan; 15(2):553-60. PubMed ID: 19147760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Jaehde U
    J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop.
    Zhang W; Shi H; Chen C; Ren K; Xu Y; Liu X; He L
    Phytomedicine; 2018 Sep; 48():51-61. PubMed ID: 30195880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
    Wang GW; Guo W; Tang XD; Peng CL; Zhao H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis.
    Song YD; Li DD; Guan Y; Wang YL; Zheng J
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):75-79. PubMed ID: 28980925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
    Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
    Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
    He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
    Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
    Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
    Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the loss of Atox1 on the cellular pharmacology of cisplatin.
    Safaei R; Maktabi MH; Blair BG; Larson CA; Howell SB
    J Inorg Biochem; 2009 Mar; 103(3):333-41. PubMed ID: 19124158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
    Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
    Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment.
    Landon CD; Benjamin SE; Ashcraft KA; Dewhirst MW
    Int J Hyperthermia; 2013 Sep; 29(6):528-38. PubMed ID: 23879689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
    Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
    Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.